Pharmaceutical company AstraZeneca has acknowledged a key mistake in the COVID-19 vaccine dosage received by some study participants
According to State Immunisation Officer Suresh Seth, there are 600 cold storage points and around 1,800 outreach sites for the universal immunisation programme for children in...
Dr M V Padma Srivastava, the chief of Neurosciences Centre, AIIMS said that anti-coronavirus vaccine 'Covaxin' being developed by Bharat Biotech in collaboration with the Indian...
In a conversation with NDTV, Dr. Soumya Swaminathan, Chief Scientist at WHO said that while vaccine candidates showing efficacy results in the range of 90 per...
With vaccines in the advance stages of development showing encouraging results raising hopes of billions of people as a way back to normalcy, the question arises,...
In U.K., the Oxford COVID-19 vaccine proved to be 90 per cent efficacious if administered at a half dose and then at a full dose
Oxford’s COVID-19 vaccine that will be called Covishield in India has produced 90 per cent immune response in one type of the dosage regimen
Dr Reddy's Laboratories in India has collaborated with Russian Direct Investment Fund to conduct mid to late-stage human trials for the Sputnik V vaccine candidate in...
The COVID-19 vaccine candidate being developed by Oxford University in collaboration with pharma company AstraZeneca is made from a weakened version of a common cold virus...
According to the Russian Direct Investment Fund, which bankrolled the development of Sputnik V COVID-19 vaccine, the cost per dose will be less than 10 USD...
Accoring to Union minister Harsh Vardhan, COVID-19 has emerged as one of the greatest global challenges, requiring a strategised, collective global response which has seen young...
As of November 24, more than 22,000 volunteers were vaccinated with the first dose and more than 19,000 volunteers with the first and the second dose...
